A 47-year-old man presented with a fever and lower extremity paresthesia. A physical examination revealed sensory deficits in the left hand, distal arm and right sole. A bone marrow aspiration demonstrated infiltration of extranodal NK/T-cell lymphoma, nasal type, and 18 F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) disclosed extensive involvement of the peripheral nerves. These findings were consistent with a diagnosis of neurolymphomatosis (NL). The lymphoma progressed soon after the patient underwent cord blood transplantation, and he died on day 33 after transplantation. NL is a rare manifestation of lymphoma characterized by infiltration of the peripheral nerves, leading to neuropathy. It is an increasingly recognized entity and can be the first indication of lymphoma.
Introduction
Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKL), is a rare lymphoma associated with EpsteinBarr virus (EBV) that is more common in East Asia than in Western populations (1) . Central nervous system (CNS) lesions are occasionally observed as sites of ENKL involvement, and extranodal involvement often leads to an unfavorable prognosis (2) .
Non-Hodgkin lymphoma (NHL) infiltrates the nervous system in approximately 10-25% of cases; however, peripheral neuropathy as a complication of lymphoma is rare, affecting 0.1-2% of patients (3) . Neurolymphomatosis (NL) is a clinical disorder that presents with signs of peripheral neuropathy due to lymphomatous infiltration of the nerves. When NL is the only manifestation, making the diagnosis is difficult because NL is generally associated with B-cell lymphomas based on biopsy or autopsy findings.
We herein report a rare, unique case of NL associated with ENKL that clinically presented as progressive painful mononeuropathy multiplex, as revealed on 18 F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET). The literature on this subject is also reviewed.
Case Report
A 47-year-old man was referred to our hospital after presenting with a fever, lower extremity paresthesia and visual disturbances lasting for three months. He had been healthy until three months before the visit, with an intermittent fever. The visual disturbances in the right eye and weakness and numbness in the left hand and foot progressed rapidly. The patient also experienced significant weight loss. His prior medical history was not significant. The patient's general appearance on admission reflected a well-developed, well-nourished Japanese man with a slight fever. His performance status was 3 according to the Eastern Cooperative Oncology Group scale. On a physical examination, neither lymphadenopathy nor hepatosplenomegaly were observed; however, patchy erythema was noted on the patient's trunk. A neurological examination revealed sensory deficits in the left hand, distal arm and right sole. Paralgesia was noted in the left lower leg and right sole. The patient had a steppage gait. The Patellar and Achilles tendon reflexes were decreased, and the cranial nerves were intact. Decreased muscle strength of 1/6 was observed in left ankle dorsiflexion. The left hand grip had decreased from 60 kg to 50 kg. The patient was considered to have mononeuritis multiplex.
The laboratory findings (Table 1) included slight anemia and thrombocytopenia, an elevated lactate dehydrogenase level and an extremely elevated ferritin level. PCR for plasma EBV yielded 3.3×10 3 copies/mL. The cerebrospinal fluid (CSF) exhibited no invasion of lymphoma cells, with a normal protein level.
A nerve conduction analysis revealed decreased compound motor action potential (CMAP) amplitudes in the right peroneal nerve (Table 2) . Two courses of high-dose methylprednisolone and intravenous immunoglobulin therapy resulted in only the transient improvement of the patient's neurological symptoms, which relapsed within a short time, while the pancytopenia worsened. The results of nerve and muscle biopsies following steroid administration were unremarkable.
Magnetic resonance imaging (MRI) of the brain and spinal nerves and computed tomography (CT) of the trunk were unremarkable. An FDG-PET scan demonstrated extensive disease involvement in the right tibial nerve, left peroneal nerve, right third facial nerve, left ulnar nerve and spine (Fig. 1) . These findings were consistent with those of NL. Finally, infiltration of CD3 + and CD56 + lymphomatous cells and hemophagocytosis were detected in the bone marrow (Fig. 2) . logical diagnosis obtained from the bone marrow specimen was ENKL. There were no gastrointestinal lesions on esophagogastroduodenoscopy. The clinical stage was determined to be IV B based on these clinical findings.
In accordance with the pathological diagnosis of the bone marrow, the patient received two courses of SMILE regimen chemotherapy; however, the disease was considered to be progressive. Cord blood transplantation was planned, followed by the administration of a reduced-intensity conditioning regimen consisting of fludarabine (125 mg/m 2 ), melphalan (140 mg/m 2 ) and 4 Gy of total body irradiation. HLA allele 5/6 matched female cord blood with 2.38×10 7 /kg of total nucleated cells (TNCs) and 1.12×10 5 /kg of CD34-positive cells were infused. On day 25, the lymphoma progressed in addition to the development of hepatomegaly, neuropathic pain and hemophagocytosis. Plasma EBV PCR showed findings of 2.4×10 5 copies/mL. Although salvage therapy was administered with a steroid pulse and etoposide, it was not effective. The patient died on day 33 after transplantation; the overall survival from onset was six months. The request for an autopsy was denied.
Discussion
The etiology of neuropathy without compression varies, including antibody-mediated nerve injury, cryoglobulinemia leading to changes in the vasa nervosum and NL. NL is a rare manifestation of lymphoma characterized by infiltration of the peripheral nerves by malignant cells, leading to neuropathy at multiple sites. A diagnosis of neuropathy in a patient with a relevant hematological malignancy should raise suspicion. However, neuropathy can be the first manifestation, as observed in the present case. Although it is difficult to exclude the possibility of neuropathy due to paraneoplastic syndrome in this case, autoimmune antibodies related to neuropathy were negative, and paraneoplastic neuropathy associated with NK/T cell lymphoma is extremely rare (4) .
Diagnosing NL is clinically challenging. Approximately 60% of NL patients have abnormal CSF findings (5) that typically include an elevated protein level and cell count. Performing a nerve biopsy may be required to make a diagnosis if there is uncertainty between the diagnoses of NL and other neuropathies. NL is more often detected antemortem, likely due to improvements in imaging resolution that can detect affected neural structures with increased precision. While MRI is clinically useful for evaluating nerve or root involvement, MRI findings are not specific for NL. Interestingly, FDG-PET appears to be a highly sensitive diagnostic method for identifying NL, with a positivity rate as high as 87.5-91% (5, 6). Intense FDG uptake in the involved nerve, as observed in this case, is a typical sign of NL according to a previous report (6) . Because the use of FDG-PET is recommended for staging studies and response assessments (7), more cases of NL are likely to be identified. In the present case, the nerve biopsies performed after several courses of high-dose steroids did not pathologically confirm the diagnosis of NL. This may explain why the steroid therapy transiently improved the lymphomatous infiltration. Another speculation is that the negative nerve biopsy resulted from the order of the clinical tests and the fact that biopsy sites were determined clinically. Indeed, had the FDG-PET findings been obtained prior to performing the biopsy, obtaining more accurate pathological results may have been possible. Widespread peripheral neuropathy that is rarely explained by other conditions was observed, and FDG-PET demonstrated increased metabolic activity and diagnostic utility. We did not perform MRI of the extremities because FDG-PET was performed first. Given the effectiveness of FDG-PET in evaluating the entire body at once, it is likely more useful than MRI for detecting NL.
Approximately 80% of reported NL cases originate from B-cells, most of which involve aggressive lymphoma (5). However, only two cases associated with NK cell lymphoma have been previously reported (8, 9) , as summarized in Table 3 . While aggressive NK cell leukemia can be distinguished due to bone marrow infiltration (10), the present case was finally diagnosed as ENKL based on the immunophenotypes of the lymphoma cells. In contrast, the pathological diagnoses in the previous two cases were not available for comparison with the recent World Health Organization (WHO) classifications (1) . Further pathological evaluations are warranted in the first case because the patient exhibited CD56 and TCR-gamma rearrangement, which is more consistent with the findings of gamma/delta T-cell lymphoma. Therefore, the present case describes the first patient with NL associated with ENKL to be confirmed on FDG-PET. ENKL is an aggressive lymphoma with a predilection for occurring at unusual sites, including the CNS, skin and nasopharynx. It follows a rapidly progressive course despite treatment with aggressive chemotherapy and stem cell transplantation, as shown in previous reports of prognostic factors (2, 11) . The optimal treatment of NHL associated with NL is not well defined. NL treatment consists of chemotherapy alone or combined with radiotherapy. To select the appropriate therapy, knowledge regarding the extent of systemic and nervous system involvement is essential. The administration of systemic chemotherapy is critical when addressing multiple sites, although no optimal regimen has been established. The feasibility of steroids, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for ENKL was recently reported (12) . Because this regimen contains high-dose methotrexate, it may be useful for treating NL. However, the two courses of SMILE administered in the present case failed, and the neuropathy did not clinically improve. The clinical symptoms of NL were aggravated even after the patient received conditioning therapy and cord blood transplantation. The median reported survival of patients with NL is 10 months from diagnosis, with a 36-month survival rate of 24% (5), which is worse than the standard outcome of Bcell NHL treated with rituximab (13) . The treatment strategies should therefore be improved.
The clinical relevance of nervous system involvement in patients with NK/T-cell lymphoma is unclear. There are no previous studies of factors that increase the risk of involvement. The present patient exhibited a high level of plasma EBV. Given that a high EBV level is associated with a poor response to chemotherapy (14) , further investigations are needed to evaluate the relationship between EBV and nervous system involvement.
In conclusion, NL is becoming increasingly detectable due to awareness of the disease and advances in imaging modalities, such as FDG-PET. The present case suggests that NL can occur with ENKL. Future studies are needed to assess the relationships between as well as prognosis and biological relevance of these conditions.
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